Can You Take Clozapine 225 mg at Bedtime?
Yes, clozapine 225 mg can be taken once daily at bedtime (qhs), and this is actually the most common dosing practice in North America, though divided dosing may be preferred in some clinical contexts.
Dosing Regimen Evidence
The FDA label does not mandate divided dosing for clozapine, stating only that the target dose of 300-450 mg/day should be "administered in divided doses" during titration to minimize orthostatic hypotension, bradycardia, and syncope 1. However, once a patient is stabilized on a maintenance dose, the dosing schedule becomes more flexible.
Real-World Practice Patterns
Once-daily dosing at bedtime is the predominant practice pattern:
- In North American settings, 75% of patients receive clozapine once daily, even when doses exceed 200 mg/day 2
- This practice occurs despite product monograph recommendations for divided dosing
- No significant difference in positive symptom remission rates exists between once-daily versus divided dosing (79.7% vs 80.5%) 2
Pharmacokinetic Considerations
The 225 mg dose falls within a therapeutic range that can be administered once daily:
- Clozapine has a half-life of 12 hours at steady state (range 4-66 hours) 1
- The elimination half-life increases with multiple dosing, supporting once-daily administration 1
- To achieve therapeutic plasma levels (350-600 ng/mL), patients on divided dosing typically require 125-225 mg daily 3
Clinical Advantages of Bedtime Dosing
Administering clozapine at bedtime offers several benefits:
- Sedation management: Clozapine causes significant sedation, with many patients sleeping 10-14 hours per night 4. Bedtime dosing leverages this side effect therapeutically
- Improved adherence: Simplified once-daily regimens may enhance medication compliance 2
- Reduced daytime impairment: Concentrating sedative effects during sleep hours minimizes functional interference
When Divided Dosing May Be Preferred
Consider divided dosing in these specific situations:
- During initial titration (first 2 weeks) to minimize orthostatic hypotension risk 1
- Higher total daily doses (>400 mg) where side effects become problematic 5
- Patients experiencing breakthrough symptoms or inadequate symptom control
- Those with significant anticholinergic side effects requiring dose distribution 5
- Patients with poor tolerance to sedation even at bedtime
Important Safety Monitoring
Regardless of dosing schedule, ensure:
- Regular ANC monitoring per clozapine REMS requirements 1
- Assessment for orthostatic hypotension, especially if recently titrated
- Monitoring for tachycardia (occurs in 68% of patients) 4
- Evaluation for gastrointestinal hypomotility and constipation 4
- Screening for metabolic side effects with concurrent metformin consideration 6
Plasma Level Considerations
For the 225 mg dose:
- Patients on once-daily dosing may have lower plasma concentrations compared to divided dosing 7
- If therapeutic response is inadequate, check plasma clozapine levels (target ≥350 ng/mL) 6
- The concentration-to-dose ratio is influenced by dosing frequency, with twice-daily dosing producing higher plasma levels 3
Common Pitfalls to Avoid
- Don't automatically switch to divided dosing if the patient is stable and adherent on once-daily dosing
- Don't ignore sedation complaints - while bedtime dosing helps, excessive daytime sleepiness may require dose adjustment or aripiprazole augmentation 4
- Don't forget drug interactions - CYP1A2 inhibitors (avoid omeprazole) and inducers (smoking) significantly affect clozapine levels 4, 1
The 225 mg qhs regimen is clinically appropriate for maintenance treatment, aligns with real-world practice patterns, and should be continued if the patient demonstrates good response and tolerability.